These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 11470322)
1. Complexities in the neurotoxic actions of 6-hydroxydopamine in relation to the cytoprotective properties of taurine. Hayes J; Tipton KF; Bianchi L; Corte LD Brain Res Bull; 2001 May; 55(2):239-45. PubMed ID: 11470322 [TBL] [Abstract][Full Text] [Related]
2. Relative involvement of globus pallidus and subthalamic nucleus in the regulation of somatodendritic dopamine release in substantia nigra is dopamine-dependent. Cobb WS; Abercrombie ED Neuroscience; 2003; 119(3):777-86. PubMed ID: 12809698 [TBL] [Abstract][Full Text] [Related]
3. The release of amino acids from rat neostriatum and substantia nigra in vivo: a dual microdialysis probe analysis. Bianchi L; Colivicchi MA; Bolam JP; Della Corte L Neuroscience; 1998 Nov; 87(1):171-80. PubMed ID: 9722150 [TBL] [Abstract][Full Text] [Related]
4. The effect of 6-hydroxydopamine lesions on the release of amino acids in the direct and indirect pathways of the basal ganglia: a dual microdialysis probe analysis. Galeffi F; Bianchi L; Bolam JP; Della Corte L Eur J Neurosci; 2003 Aug; 18(4):856-68. PubMed ID: 12925011 [TBL] [Abstract][Full Text] [Related]
5. Extracellular taurine in the substantia nigra: taurine-glutamate interaction. García Dopico J; Perdomo Díaz J; Alonso TJ; González Hernández T; Castro Fuentes R; Rodríguez Díaz M J Neurosci Res; 2004 May; 76(4):528-38. PubMed ID: 15114625 [TBL] [Abstract][Full Text] [Related]
6. Intrapallidal injection of 6-hydroxydopamine induced changes in dopamine innervation and neuronal activity of globus pallidus. Bouali-Benazzouz R; Tai CH; Chetrit J; Benazzouz A Neuroscience; 2009 Dec; 164(2):588-96. PubMed ID: 19628021 [TBL] [Abstract][Full Text] [Related]
7. Release of dopamine by perfusion with 1-methyl-4-phenylpyridinium ion (MPP(+)) into the striatum is associated with hydroxyl free radical generation. Obata T; Yamanaka Y; Kinemuchi H; Oreland L Brain Res; 2001 Jul; 906(1-2):170-5. PubMed ID: 11430875 [TBL] [Abstract][Full Text] [Related]
8. Stress-induced increase in extracellular dopamine in striatum: role of glutamatergic action via N-methyl-D-aspartate receptors in substantia nigra. Castro SL; Zigmond MJ Brain Res; 2001 May; 901(1-2):47-54. PubMed ID: 11368949 [TBL] [Abstract][Full Text] [Related]
9. Dopaminergic innervation of the rat globus pallidus characterized by microdialysis and immunohistochemistry. Fuchs H; Hauber W Exp Brain Res; 2004 Jan; 154(1):66-75. PubMed ID: 14508630 [TBL] [Abstract][Full Text] [Related]
10. Pallidal control of substantia nigra dopaminergic neuron firing pattern and its relation to extracellular neostriatal dopamine levels. Lee CR; Abercrombie ED; Tepper JM Neuroscience; 2004; 129(2):481-9. PubMed ID: 15501605 [TBL] [Abstract][Full Text] [Related]
11. Loss of the preferential control over the striato-nigral direct pathway by striatal NMDA receptors in a rat model of Parkinson's disease. Morari M; Fantin M Analyst; 2015 Jun; 140(11):3830-9. PubMed ID: 25584655 [TBL] [Abstract][Full Text] [Related]
13. Changes of amino acid and monoamine levels after neonatal 6-hydroxydopamine denervation in rat basal ganglia, substantia nigra, and Raphe nuclei. Molina-Holgado E; Dewar KM; Grondin L; van Gelder NM; Reader TA J Neurosci Res; 1993 Jul; 35(4):409-18. PubMed ID: 8360949 [TBL] [Abstract][Full Text] [Related]
14. Dose- and sex-dependent effects of the neurotoxin 6-hydroxydopamine on the nigrostriatal dopaminergic pathway of adult rats: differential actions of estrogen in males and females. Murray HE; Pillai AV; McArthur SR; Razvi N; Datla KP; Dexter DT; Gillies GE Neuroscience; 2003; 116(1):213-22. PubMed ID: 12535954 [TBL] [Abstract][Full Text] [Related]
15. Modulation of neurotransmitter release by cholecystokinin in the neostriatum and substantia nigra of the rat: regional and receptor specificity. You ZB; Herrera-Marschitz M; Pettersson E; Nylander I; Goiny M; Shou HZ; Kehr J; Godukhin O; Hökfelt T; Terenius L; Ungerstedt U Neuroscience; 1996 Oct; 74(3):793-804. PubMed ID: 8884775 [TBL] [Abstract][Full Text] [Related]
17. Glial cell line-derived neurotrophic factor attenuates behavioural deficits and regulates nigrostriatal dopaminergic and peptidergic markers in 6-hydroxydopamine-lesioned adult rats: comparison of intraventricular and intranigral delivery. Lapchak PA; Miller PJ; Collins F; Jiao S Neuroscience; 1997 May; 78(1):61-72. PubMed ID: 9135089 [TBL] [Abstract][Full Text] [Related]
18. Subtype selective antagonism of substantia nigra pars compacta Group I metabotropic glutamate receptors protects the nigrostriatal system against 6-hydroxydopamine toxicity in vivo. Vernon AC; Zbarsky V; Datla KP; Croucher MJ; Dexter DT J Neurochem; 2007 Nov; 103(3):1075-91. PubMed ID: 17714448 [TBL] [Abstract][Full Text] [Related]
19. PEC-60 increases dopamine but not GABA release in the dorsolateral neostriatum of the halothane anaesthetized rat. An in vivo microdialysis study. Rimondini R; O'Connor WT; Ferré S; Sillard R; Agerberth B; Mutt V; Ungerstedt U; Fuxe K Neurosci Lett; 1994 Aug; 177(1-2):53-7. PubMed ID: 7824182 [TBL] [Abstract][Full Text] [Related]
20. Tonic GABA-ergic modulation of striatal dopamine release studied by in vivo microdialysis in the freely moving rat. Smolders I; De Klippel N; Sarre S; Ebinger G; Michotte Y Eur J Pharmacol; 1995 Sep; 284(1-2):83-91. PubMed ID: 8549640 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]